Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves' disease) in a 16-year-old male with Kabuki syndrome.

Multiple endocrine neoplasia type 2A (MEN2A) is caused by germline pathogenic variants in the RET proto-oncogene and is characterized by medullary thyroid cancer (MTC), pheochromocytoma, and hyperparathyroidism. Autoimmune polyendocrine syndromes (APS) are defined as multiple endocrine gland insufficiency associated with loss of immune tolerance. APS type 2 (APS-2) consists of at least two of the following diseases: type 1 diabetes mellitus (T1DM), autoimmune thyroid disease, and Addison's disease. We describe the clinical, molecular, and biochemical findings of MEN2A, APS-2, and Kabuki syndrome (KS) in a 16-year-old male. Whole exome sequencing was performed to identify the genetic cause of the pheochromocytoma and syndromic features including facial dysmorphism, developmental delay, and epilepsy. RET pathogenic variant and KMT2D pathogenic variant were identified, and he was diagnosed with MEN2A and KS. This is the first case of association between MEN2 and APS in adolescence and the second proven case in humans. In addition, this is the first report of MEN2 and APS in KS.

[1]  Carlos Pérez-Plascencia,et al.  Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered , 2022, Frontiers in Genetics.

[2]  S. Y. Kim,et al.  Clinical features and signaling effects of RET D631Y variant multiple endocrine neoplasia type 2 (MEN2) , 2021, The Korean journal of internal medicine.

[3]  H. Salhi,et al.  Pheochromocytoma and Glucoregulation Disorders , 2021, Annals of African medicine.

[4]  F. Galuppini,et al.  First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans. , 2020, Endocrine journal.

[5]  Jian Wang,et al.  Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms , 2019, World Journal of Pediatrics.

[6]  N. Matsumoto,et al.  Cancer Management in Kabuki Syndrome: The First Case of Wilms Tumor and a Literature Review , 2018, Journal of pediatric hematology/oncology.

[7]  T. Bunchman,et al.  Review of Pediatric Pheochromocytoma and Paraganglioma , 2017, Front. Pediatr..

[8]  C. Sainsbury,et al.  A Practical Review of C-Peptide Testing in Diabetes , 2017, Diabetes Therapy.

[9]  T. Meitinger,et al.  Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X‐Linked Kabuki Syndrome Subtype 2 , 2016, Human mutation.

[10]  A. Topaloğlu,et al.  Coexistence of Kabuki Syndrome and Autoimmune Thyroiditis , 2016, Journal of clinical research in pediatric endocrinology.

[11]  2. Classification and Diagnosis of Diabetes , 2014, Diabetes Care.

[12]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  Carla J. Greenbaum,et al.  Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes , 2014, Diabetes Care.

[14]  Dae-Yeol Lee,et al.  Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents , 2014, Annals of pediatric endocrinology & metabolism.

[15]  Charis Eng,et al.  Multiple endocrine neoplasia type 2: An overview , 2011, Genetics in Medicine.

[16]  H. Gharib,et al.  Medullary thyroid cancer: management guidelines of the American Thyroid Association. , 2009, Thyroid : official journal of the American Thyroid Association.

[17]  J. Perheentupa,et al.  Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I , 2009, Journal of internal medicine.

[18]  J. Pablo,et al.  An unusual association: pheochromocytoma on an atrophied adrenal gland due to addison's disease. , 2008, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[19]  R. Haba,et al.  A case of pheochromocytoma complicated with slowly progressive type 1 diabetes mellitus and chronic thyroiditis , 2007, Endocrine.

[20]  E. Zackai,et al.  Autoimmune disorders in Kabuki syndrome , 2005, American journal of medical genetics. Part A.

[21]  C. Betterle,et al.  Update on autoimmune polyendocrine syndromes (APS). , 2003, Acta bio-medica : Atenei Parmensis.

[22]  P. Fain,et al.  The genetics of autoimmune polyendocrine syndrome type II. , 2002, Endocrinology and metabolism clinics of North America.

[23]  L. Peltonen,et al.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.

[24]  Shinsei Minoshima,et al.  Positional cloning of the APECED gene , 1997, Nature Genetics.

[25]  G. Lenoir,et al.  RET proto-oncogene mutations in French MEN 2A and FMTC families. , 1994, Human molecular genetics.

[26]  É. G. Il'ina,et al.  KABUKI SYNDROME , 2015, Cassidy and Allanson's Management of Genetic Syndromes.

[27]  BOULIN,et al.  Classification and Diagnosis of Diabetes. , 2022, Primary care.